Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1852044 (
HS3
)
171
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Escherichia coli strain
HS3
, metabolically engineered to have Met(-), AHV(r), Ile(L) and AEC(r) characteristics, produced 58.0 g/l of L-threonine, but it was neither salt-tolerant nor osmotolerant; and the growth and
threonine
production of the strain were severely inhibited both by the addition of NaCl with a concentration higher than 2% and by the presence of glucose with a concentration higher than 10%. Therefore, salt-tolerant mutants were isolated. The salt-tolerant mutants, HS454 and HS528 which were derived from strain
HS3
, were both tolerant to salt (2%) and hyper-productive. The growth and L-threonine production by the mutant strain HS454 were almost unaffected by a glucose concentration lower than 10%, but gradually reduced with increasing glucose concentration, up to 15%. However, the mutant strain HS528 showed slightly enhanced growth and L-threonine production with increasing glucose concentration, up to 10-12.5%. Strains HS454 and HS528 produced 69.8 g/l and 74.0 g/l of L-threonine, respectively in a 5-1 jar fermentor.
...
PMID:Characterization of salt-tolerant mutant for enhancement of L-threonine production in Escherichia coli. 1113 89